NCT00397384 2015-09-30Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerNational Cancer Institute (NCI)Phase 1 Completed43 enrolled
NCT00101348 2014-06-11Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/2 Completed66 enrolled
NCT00030498 2013-01-16Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionNational Cancer Institute (NCI)Phase 1 Completed75 enrolled
NCT00063895 2013-01-09Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckNational Cancer Institute (NCI)Phase 1/2 Completed80 enrolled